4//SEC Filing
Moran Michael Shawn 4
Accession 0001209191-22-006051
CIK 0000827871other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 6:46 PM ET
Size
4.8 KB
Accession
0001209191-22-006051
Insider Transaction Report
Form 4
Moran Michael Shawn
EVP, Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2022-01-31$45.94/sh−210$9,647→ 22,457 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy withholding tax obligations.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001886788
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 6:46 PM ET
- Size
- 4.8 KB